Showing results (371-380 of 395) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast CancerFabio Conforti, Valentina Nekljudova, Isabella Sala, et al.The Lancet. Oncology|November 22, 2017
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trialMarco Colleoni, Weixiu Luo, Per Karlsson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFTPrudence A Francis, Gini F Fleming, István Láng, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.The New England Journal of Medicine|October 21, 2005
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancerMartine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, et al.European Journal of Cancer (Oxford, England : 1990)|March 25, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, et al.Cancer|September 23, 2025
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFTKarin Ribi, Bernard F Cole, Gini F Fleming, et al.The New England Journal of Medicine|December 16, 2014
Adjuvant ovarian suppression in premenopausal breast cancerPrudence A Francis, Meredith M Regan, Gini F Fleming, et al.Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.Pageof 40